169 related articles for article (PubMed ID: 34959310)
1. The Very First Modification of Pleuromutilin and Lefamulin by Photoinitiated Radical Addition Reactions-Synthesis and Antibacterial Studies.
Thai Le S; Páll D; Rőth E; Tran T; Debreczeni N; Bege M; Bereczki I; Ostorházi E; Milánkovits M; Herczegh P; Borbás A; Csávás M
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959310
[TBL] [Abstract][Full Text] [Related]
2. Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia.
Zhanel GG; Deng C; Zelenitsky S; Lawrence CK; Adam HJ; Golden A; Berry L; Schweizer F; Zhanel MA; Irfan N; Bay D; Lagacé-Wiens P; Walkty A; Mandell L; Lynch JP; Karlowsky JA
Drugs; 2021 Feb; 81(2):233-256. PubMed ID: 33247830
[TBL] [Abstract][Full Text] [Related]
3. A modular and enantioselective synthesis of the pleuromutilin antibiotics.
Murphy SK; Zeng M; Herzon SB
Science; 2017 Jun; 356(6341):956-959. PubMed ID: 28572392
[TBL] [Abstract][Full Text] [Related]
4. Pleuromutilins: Potent Drugs for Resistant Bugs-Mode of Action and Resistance.
Paukner S; Riedl R
Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 27742734
[TBL] [Abstract][Full Text] [Related]
5. Lefamulin: A Novel Semisynthetic Pleuromutilin Antibiotic for Community-acquired Bacterial Pneumonia.
Watkins RR; File TM
Clin Infect Dis; 2020 Dec; 71(10):2757-2762. PubMed ID: 32221520
[TBL] [Abstract][Full Text] [Related]
6. Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic.
Veve MP; Wagner JL
Pharmacotherapy; 2018 Sep; 38(9):935-946. PubMed ID: 30019769
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.
Li YG; Wang JX; Zhang GN; Zhu M; You XF; Wang YC; Zhang F
Bioorg Med Chem Lett; 2020 Apr; 30(7):126969. PubMed ID: 32014384
[TBL] [Abstract][Full Text] [Related]
8. Efficient antibacterial agents: a review of the synthesis, biological evaluation and mechanism of pleuromutilin derivatives.
Shang R; Wang J; Guo W; Liang J
Curr Top Med Chem; 2013; 13(24):3013-25. PubMed ID: 24200363
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in developing modified C14 side chain pleuromutilins as novel antibacterial agents.
Liu Y; Zhou Q; Huo Y; Sun X; Hu J
Eur J Med Chem; 2024 Apr; 269():116313. PubMed ID: 38503168
[TBL] [Abstract][Full Text] [Related]
10. Lefamulin: The First Systemic Pleuromutilin Antibiotic.
Chahine EB; Sucher AJ
Ann Pharmacother; 2020 Dec; 54(12):1203-1214. PubMed ID: 32493034
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Antibacterial Activity Against MRSA of Pleuromutilin Derivatives Possessing a Mercaptoethylamine Linker.
Zhang ZS; Huang YZ; Luo J; Wang BF; Jin Z; Liu YH; Tang YZ
Med Chem; 2018; 14(6):585-594. PubMed ID: 29663895
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Biological Activity Evaluation of Novel Heterocyclic Pleuromutilin Derivatives.
Yi Y; Fu Y; Dong P; Qin W; Liu Y; Liang J; Shang R
Molecules; 2017 Jun; 22(6):. PubMed ID: 28617344
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Activity of Thioguanine-Modified Pleuromutilin Derivatives.
Yong C; Yu J; Wu C; Zhang X; Li Y; Xie C; He X; Liu D; Wang Z; Lai P; Zhang Y
ACS Med Chem Lett; 2023 Jun; 14(6):737-745. PubMed ID: 37312858
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Biological Evaluation of Novel Thioether Pleuromutilin Derivatives.
Mu S; Liu H; Zhang L; Wang X; Xue F; Zhang Y
Biol Pharm Bull; 2017; 40(8):1165-1173. PubMed ID: 28768998
[TBL] [Abstract][Full Text] [Related]
15. The pleuromutilin antibiotics: a new class for human use.
Novak R; Shlaes DM
Curr Opin Investig Drugs; 2010 Feb; 11(2):182-91. PubMed ID: 20112168
[TBL] [Abstract][Full Text] [Related]
16. Determination of In Vitro Antimicrobial Susceptibility for Lefamulin (Pleuromutilin) for
Spiller-Boulter O; Paukner S; Boostrom I; Sands K; Portal EAR; Spiller OB
Antibiotics (Basel); 2021 Nov; 10(11):. PubMed ID: 34827308
[TBL] [Abstract][Full Text] [Related]
17. Pleuromutilin and its derivatives-the lead compounds for novel antibiotics.
Tang YZ; Liu YH; Chen JX
Mini Rev Med Chem; 2012 Jan; 12(1):53-61. PubMed ID: 22070694
[TBL] [Abstract][Full Text] [Related]
18. A click chemistry approach to pleuromutilin derivatives, part 2: conjugates with acyclic nucleosides and their ribosomal binding and antibacterial activity.
Dreier I; Kumar S; Søndergaard H; Rasmussen ML; Hansen LH; List NH; Kongsted J; Vester B; Nielsen P
J Med Chem; 2012 Mar; 55(5):2067-77. PubMed ID: 22280300
[TBL] [Abstract][Full Text] [Related]
19. Directed C-H Bond Oxidation of (+)-Pleuromutilin.
Ma X; Kucera R; Goethe OF; Murphy SK; Herzon SB
J Org Chem; 2018 Jul; 83(13):6843-6892. PubMed ID: 29664634
[TBL] [Abstract][Full Text] [Related]
20. Tissue Distribution of [
Wicha WW; Henson C; Webbley K; Gelone SP
Antimicrob Agents Chemother; 2022 Aug; 66(8):e0035522. PubMed ID: 35862748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
